The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"YojJ-like
".
FunFam 4: TYRO protein tyrosine kinase-binding protein
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 7 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
5 | A6Y956 (/IPI) O43914 (/IPI) O54885 (/IPI) O54885 (/IPI) Q6X9T7 (/IPI) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
3 | O43914 (/IPI) O54885 (/IPI) O54885 (/IPI) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | O43914 (/ISS) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | O43914 (/TAS) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | O43914 (/IPI) |
There are 66 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
11 |
A4F4L0 (/ISS)
A4F4L0 (/ISS)
O43914 (/ISS)
Q6X9T7 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q95J79 (/ISS)
(1 more) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
3 | O43914 (/IMP) O54885 (/IMP) O54885 (/IMP) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
3 | O43914 (/IMP) O54885 (/IMP) O54885 (/IMP) |
Positive regulation of macrophage fusion GO:0034241
Any process that activates or increases the frequency, rate or extent of macrophage fusion.
|
3 | O43914 (/IMP) O54885 (/IMP) O54885 (/IMP) |
Myeloid leukocyte activation GO:0002274
A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Macrophage activation involved in immune response GO:0002281
A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Microglial cell activation involved in immune response GO:0002282
The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Neutrophil activation involved in immune response GO:0002283
The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Integrin-mediated signaling pathway GO:0007229
A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Actin cytoskeleton organization GO:0030036
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | O54885 (/IGI) O54885 (/IGI) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
|
2 | O54885 (/IDA) O54885 (/IDA) |
Positive regulation of natural killer cell activation GO:0032816
Any process that activates or increases the frequency, rate or extent of natural killer cell activation.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Negative regulation of transforming growth factor beta1 production GO:0032911
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Positive regulation of macrophage fusion GO:0034241
Any process that activates or increases the frequency, rate or extent of macrophage fusion.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Positive regulation of tumor necrosis factor biosynthetic process GO:0042535
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Negative regulation of interleukin-10 biosynthetic process GO:0045081
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-10.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of interleukin-6 biosynthetic process GO:0045410
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Response to axon injury GO:0048678
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of interleukin-1 beta biosynthetic process GO:0050725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
2 | O54885 (/ISS) O54885 (/ISS) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Positive regulation of hippocampal neuron apoptotic process GO:0110090
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process in hippocampal neurons.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Negative regulation of long-term synaptic potentiation GO:1900272
Any process that stops, prevents or reduces the frequency, rate or extent of long-term synaptic potentiation.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of receptor localization to synapse GO:1902685
Any process that activates or increases the frequency, rate or extent of receptor localization to synapse.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of microglial cell mediated cytotoxicity GO:1904151
Any process that activates or increases the frequency, rate or extent of microglial cell mediated cytotoxicity.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Positive regulation of protein localization to cell surface GO:2000010
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Regulation of osteoclast development GO:2001204
Any process that modulates the frequency, rate or extent of osteoclast development.
|
2 | O54885 (/IGI) O54885 (/IGI) |
Positive regulation of osteoclast development GO:2001206
Any process that activates or increases the frequency, rate or extent of osteoclast development.
|
2 | O54885 (/IMP) O54885 (/IMP) |
Myeloid leukocyte activation GO:0002274
A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | O43914 (/IDA) |
Microglial cell activation involved in immune response GO:0002282
The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
|
1 | O43914 (/ISS) |
Cellular defense response GO:0006968
A defense response that is mediated by cells.
|
1 | O43914 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | O43914 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | O43914 (/ISS) |
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
|
1 | A6Y956 (/IPI) |
Actin cytoskeleton organization GO:0030036
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
|
1 | O43914 (/ISS) |
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
|
1 | O43914 (/ISS) |
Negative regulation of transforming growth factor beta1 production GO:0032911
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.
|
1 | O43914 (/ISS) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
1 | O43914 (/ISS) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
1 | O43914 (/TAS) |
Positive regulation of tumor necrosis factor biosynthetic process GO:0042535
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
1 | O43914 (/ISS) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
1 | O43914 (/TAS) |
Negative regulation of interleukin-10 biosynthetic process GO:0045081
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-10.
|
1 | O43914 (/ISS) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
1 | O43914 (/TAS) |
Positive regulation of interleukin-6 biosynthetic process GO:0045410
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
|
1 | O43914 (/ISS) |
Response to axon injury GO:0048678
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
|
1 | O43914 (/ISS) |
Positive regulation of interleukin-1 beta biosynthetic process GO:0050725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.
|
1 | O43914 (/ISS) |
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
1 | O43914 (/TAS) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
1 | O43914 (/IDA) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
1 | O43914 (/IMP) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
1 | O43914 (/ISS) |
Positive regulation of hippocampal neuron apoptotic process GO:0110090
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process in hippocampal neurons.
|
1 | O43914 (/ISS) |
Negative regulation of long-term synaptic potentiation GO:1900272
Any process that stops, prevents or reduces the frequency, rate or extent of long-term synaptic potentiation.
|
1 | O43914 (/ISS) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
1 | O43914 (/ISS) |
Positive regulation of receptor localization to synapse GO:1902685
Any process that activates or increases the frequency, rate or extent of receptor localization to synapse.
|
1 | O43914 (/ISS) |
Positive regulation of microglial cell mediated cytotoxicity GO:1904151
Any process that activates or increases the frequency, rate or extent of microglial cell mediated cytotoxicity.
|
1 | O43914 (/ISS) |
Positive regulation of protein localization to cell surface GO:2000010
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
|
1 | O43914 (/IMP) |
Positive regulation of osteoclast development GO:2001206
Any process that activates or increases the frequency, rate or extent of osteoclast development.
|
1 | O43914 (/ISS) |
There are 9 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
12 |
A4F4L0 (/ISS)
A4F4L0 (/ISS)
O54885 (/ISS)
O54885 (/ISS)
Q6X9T7 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
Q8WNQ8 (/ISS)
(2 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | O43914 (/TAS) O54885 (/TAS) O54885 (/TAS) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
3 | O43914 (/IDA) O54885 (/IDA) O54885 (/IDA) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
2 | O54885 (/IDA) O54885 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | O54885 (/ISO) O54885 (/ISO) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
1 | O43914 (/ISS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | O43914 (/TAS) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | O43914 (/TAS) |
Secretory granule membrane GO:0030667
The lipid bilayer surrounding a secretory granule.
|
1 | O43914 (/TAS) |